Craniopharyngioma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:


General ''imaging differential'' considerations include:
General ''imaging differential'' considerations include:
#Rathke cleft cyst
*Rathke cleft cyst
**No solid or enhancing component
**No solid or enhancing component
**Calcification is rare
**Calcification is rare
**Unilocular
**Unilocular
**Majority are completely or mostly intrasellar
**Majority are completely or mostly intrasellar
##Pituitary macroadenoma (with cystic degeneration or necrosis)
*Pituitary macroadenoma (with cystic degeneration or necrosis)
**Can look very similar
**Can look very similar
**Usually has intrasellar epicentre with pituitary fossa enlargement rather than suprasellar epicentre
**Usually has intrasellar epicentre with pituitary fossa enlargement rather than suprasellar epicentre
**Despite occasional presence of T1 bright cystic regions, calcification in these cases is often absent (whereas most adamantinomatous craniopharyngiomas are calcified)
**Despite occasional presence of T1 bright cystic regions, calcification in these cases is often absent (whereas most adamantinomatous craniopharyngiomas are calcified)
###Intracranial teratoma
*Intracranial teratoma
**Presence of fat is helpful, but requires fat saturated sequences or CT to confirm
**Presence of fat is helpful, but requires fat saturated sequences or CT to confirm



Revision as of 17:42, 22 August 2015

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma differential diagnosis

CDC on Craniopharyngioma differential diagnosis

Craniopharyngioma differential diagnosis in the news

Blogs on Craniopharyngioma differential diagnosis

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Craniopharyngioma from other Diseases

There are various conditions that must be differentiated from craniopharyngioma clinically:

  • Pituitary adenoma
  • Optic chiasma glioma
  • Tuberculum sellae meningioma
  • Tumor of third ventricle
  • Lateral ventricles chorioidopapilloma

General imaging differential considerations include:

  • Rathke cleft cyst
    • No solid or enhancing component
    • Calcification is rare
    • Unilocular
    • Majority are completely or mostly intrasellar
  • Pituitary macroadenoma (with cystic degeneration or necrosis)
    • Can look very similar
    • Usually has intrasellar epicentre with pituitary fossa enlargement rather than suprasellar epicentre
    • Despite occasional presence of T1 bright cystic regions, calcification in these cases is often absent (whereas most adamantinomatous craniopharyngiomas are calcified)
  • Intracranial teratoma
    • Presence of fat is helpful, but requires fat saturated sequences or CT to confirm

References


Template:WikiDoc Sources